Treatment of ADHD: Guanfacine Extended Release in ADHD

Abstract

Investigators at Massachusetts General Hospital, Boston, MA, performed a multicenter, 9-week, double-blind, placebo-controlled, dose-optimization study of guanfacine extended release (GXR, <4 mg/d) adjunctive to a long-acting psychostimulant for ADHD continued in 461 subjects.

Keywords

• guanfacine extended release
• psychostimulant
• tenex